Compugen | CGEN - Assets


Compugen reported $97.84M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Arca Biopharma USD 509.25M 151.83M Sep/2025
aTyr Pharma USD 106.65M 5.12M Sep/2025
Bio Path USD 746K 1.45M Jun/2025
Brainstorm Cell Therapeutics USD 1.38M 1.19M Sep/2025
Cara Therapeutics USD 43.75M 4.8M Jun/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 97.84M 8.68M Sep/2025
Immunic USD 40.7M 20.72M Sep/2025
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Minerva Neurosciences USD 97.97M 69.88M Dec/2025
RedHill Biopharma USD 18.38M 332K Jun/2025
TherapeuticsMD USD 40.13M 1.96M Jun/2024